Clover Biopharmaceuticals, Ltd. SEC filings CBPHF
Clover Biopharmaceuticals, Ltd. has 6 filings in SEC EDGAR's recent list, going back to Apr 28, 2021. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Apr 29, 2026 | — |
| D/A | Filing | Apr 28, 2025 | — |
| D | Filing | Apr 12, 2024 | — |
| D/A | Filing | May 9, 2023 | — |
| D/A | Filing | May 24, 2022 | — |
| D | Filing | Apr 28, 2021 | — |
Showing 6 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Listed as
- CBPHF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Chengdu, China
- SEC CIK
- 1856491
Source: SEC EDGAR filings. This is company-reported data, not investment advice.